Spirulina (FEM-102) Supplement to Chronic Hepatitis B Patients

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

August 30, 2020

Study Completion Date

November 30, 2020

Conditions
Chronic Hepatitis b
Interventions
DIETARY_SUPPLEMENT

Spirulina

Spirulina, as demonstrated in previous researches in vitro and in animals, can regulate immunity, enhance anti-virus activity, lower inflammation response and slower tumor progression. Liver function and liver fibrosis is improved by Spirulina as well. In our recent clinical trial, hepatitis B patients that received anti-virus medicine orally and was supplemented with Spirulina FEM-102 showed lower qHBsAg, reflecting the clearance of cccDNA. It might be related to immune modulation against HBV, which is induced by Spirulina.

Trial Locations (1)

116

Wanfang Hospital, Taipei

All Listed Sponsors
collaborator

Far East Bio-Tec Co., Ltd

INDUSTRY

lead

Taipei Medical University WanFang Hospital

OTHER

NCT04718831 - Spirulina (FEM-102) Supplement to Chronic Hepatitis B Patients | Biotech Hunter | Biotech Hunter